DIALYSIS SYMPTOMS AND ANXIETYNCT06382714
Virtual Museum Visit on Dialysis Symptoms and Anxiety in Hemodialysis Patients
A study testing For the intervention group, a museum visit with virtual reality glasses will be applied. in people with DIALYSIS SYMPTOMS AND ANXIETY, run by Cumhuriyet University at 1 site in Turkey (Türkiye).
Trial summary
The main purpose of dialysis used in the treatment of end-stage renal failure is; By relieving the patient from uremic symptoms, controlling excess fluid, electrolyte and acid base disorders, improving the well-being of the patients and also improving the quality of life of the patients. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- DIALYSIS SYMPTOMS AND ANXIETY
- What is being tested?
- For the intervention group, a museum visit with virtual reality glasses will be applied.
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 May 2024to 31 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Patients who have been receiving hemodialysis treatment for at least one year, who are 18 years of age or older, who do not have difficulty in communicating, who are competent to answer all the questions, who do not have serious mental illness or mental problems, and who agree to participate in the research will be included in the study.
Who cannot join
- Those who have just started hemodialysis treatment (< 1 year), those who have vision or hearing problems, those who have difficulty communicating, those under the age of 18, and those who do not want to participate in the study or want to leave will be excluded from the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Efects of Virtual Museum Visit on Dialysis Symptoms and Anxiety in Hemodialysis Patients
The main purpose of dialysis used in the treatment of end-stage renal failure is; By relieving the patient from uremic symptoms, controlling excess fluid, electrolyte and acid base disorders, improving the well-being of the patients and also improving the quality of life of the patients. In addition to its contribution to the continuation of life, dialysis can significantly affect the biological and physiological balance and normal life order of patients. Some of these effects may be negative on patients. During this process, patients may frequently experience symptoms such as changes in fluid-electrolyte balance, increased fatigue, and weakness, as well as psychopathological conditions such as anxiety. In this context, it is extremely important to handle patients from a holistic perspective and keep their homeostatic balance under control during the hemodialysis process. In addition to pharmacological treatments, many integrative methods are used in the management of symptoms for reasons such as being low in cost, having fewer side effects than pharmacological treatments, and strengthening the immune system. Museum visit, one of these integrative treatment methods, has become an area of art therapy where help is received for various reasons such as coping with the symptoms of chronic diseases, reducing the side effects of medications, preventing mental depression, strengthening healthy behaviors, and avoiding tension and loss of control. In this context, the research was planned as a randomized controlled study investigating the effect of virtual museum tour on dialysis symptom index and anxiety in hemodialysis patients..T.R. The "https://sanalmuze.gov.tr" site belonging to the Ministry of Culture and Tourism will be shown to the patients five times and the virtual museum visit will be made by showing the patient's preferred museum five times among the 53 museums prepared by the General Directorate of Information Technologies of the Ministry of Culture and Tourism, and the Initiative Group, Control It will be compared with its group. Research data; It will be collected using the Patient Information Form, Dialysis Symptom Index and Beck Anxiety Scale (BAI). At the end of the study, the data will be evaluated in the SPSS program. The museum visit applied to the Intervention Group will also be applied to the control group after the study is completed, taking into account the ethical dimension.
- Conditions
- DIALYSIS SYMPTOMS AND ANXIETY
- Being tested
- For the intervention group, a museum visit with virtual reality glasses will be applied.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
For the intervention group, a museum visit with virtual reality glasses will be applied.Other
Patients will visit a museum while undergoing hemodialysis with virtual reality glasses for a total of five sessions for intervention group
| Study group | Role | What they receive |
|---|---|---|
| Art Therapy Intervention Group | Experimental | A total of five sessions of museum visits will applied to the patients in the intervention group, lasting 20-30 minutes during dialysis. The scales will administered to the individuals in the intervention groups three times in total.
The intervention group is the group in which museum visit will applied. They receives 3 sessions of hemodialysis per week. Receives: Other: For the intervention group, a museum visit with virtual reality glasses will be applied. |
| Control Group | No intervention | No virtual museum visit was applied to the control group. Scales were applied to individuals. For the control group, evaluations were made with scales three times in total. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dialysis Symptom Index (DSI)
It was developed by HD patients in order to determine the symptoms experienced by HD patients and the level of impact on the patient. The scale, developed from the Memorial Symptom Diagnosis Scale Short Form, consists of 30 items. Responses are obtained on a 5-point Likert scale. The total scale score is obtained by adding up the scores obtained. This value varies between "0-15 0". The value "0" indicates that there is no symptom. The increase in the total points given to the answers towards 150 points shows that the effect of the mentioned symptom is increasing. The internal consistency coefficient of the scale was determined as 0.84.
Measured: It will take 5 weeks to collect data three times after randomization is done. The first measurement of dialyis symptom index will be done in the first week, the second measurement in the third week and the third measurement in the fifth week.
Beck Anxiety Scale (BAI)
It measures the frequency of anxiety symptoms experienced by the individual. It is a Likert-type self-evaluation scale consisting of twenty-one items and scored between 0-3. A high total score indicates the level of anxiety experienced by the person. The validity and reliability of the scale was determined in our country.
Measured: It will take 5 weeks to collect data three times after randomization is done. The first measurement of Beck anxiety scale will be done in the first week, the second measurement in the third week and the third measurement in the fifth week.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2024
- Study start15 May 2024
- Primary completion30 Aug 2024
- Study completion31 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for DIALYSIS SYMPTOMS AND ANXIETYStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cumhuriyet University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mukadder Mollaoğlu, Cumhuriyet University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06382714
- Sponsor's protocol ID
- 2023-12/13
- Status last verified
- Apr 2024
- First submitted
- 18 Apr 2024
- Last updated
- 21 Jan 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Publications
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
PubMed 3204199Ulusoy M, Şahin N, Erkman H. Turkish Version of The Beck Anxiety Inventory: psychometric Properties. J Cognitive Psychotherapy: Int Quaterly. 1998; 12: 28-35.
Weisbord SD, Fried LF, Arnold RM, Rotondi AJ, Fine MJ, Levenson DJ, Switzer GE. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. J Pain Symptom Manage. 2004 Mar;27(3):226-40. doi: 10.1016/j.jpainsymman.2003.07.004.
PubMed 15010101
Study at a glance
From the registry record, last updated by the sponsor on 21 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efects of Virtual Museum Visit on Dialysis Symptoms and Anxiety in Hemodialysis Patients
- ClinicalTrials.gov ID
- NCT06382714
- Acronym / sponsor ID
- 2023-12/13
- Conditions
- DIALYSIS SYMPTOMS AND ANXIETY
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Cumhuriyet UniversityUniversity, hospital or other
- Study start
- 15 May 2024 (actual)
- Primary completion
- 30 Aug 2024 (actual)
- Study completion
- 31 Dec 2024 (actual)
- First posted
- 24 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main purpose of dialysis used in the treatment of end-stage renal failure is; By relieving the patient from uremic symptoms, controlling excess fluid, electrolyte and acid base disorders, improving the well-being of the patients and also improving the quality of life of the patients. In addition to its contribution to the continuation of life, dialysis can significantly affect the biological and physiological balance and normal life order of patients. Some of these effects may be negative on patients. During this process, patients may frequently experience symptoms such as changes in fluid-electrolyte balance, increased fatigue, and weakness, as well as psychopathological conditions such as anxiety. In this context, it is extremely important to handle patients from a holistic perspective and keep their homeostatic balance under control during the hemodialysis process. In addition to pharmacological treatments, many integrative methods are used in the management of symptoms for reasons such as being low in cost, having fewer side effects than pharmacological treatments, and strengthening the immune system. Museum visit, one of these integrative treatment methods, has become an area of art therapy where help is received for various reasons such as coping with the symptoms of chronic diseases, reducing the side effects of medications, preventing mental depression, strengthening healthy behaviors, and avoiding tension and loss of control. In this context, the research was planned as a randomized controlled study investigating the effect of virtual museum tour on dialysis symptom index and anxiety in hemodialysis patients..T.R. The "https://sanalmuze.gov.tr" site belonging to the Ministry of Culture and Tourism will be shown to the patients five times and the virtual museum visit will be made by showing the patient's preferred museum five times among the 53 museums prepared by the General Directorate of Information Technologies of the Ministry of Culture and Tourism, and the Initiative Group, Control It will be compared with its group. Research data; It will be collected using the Patient Information Form, Dialysis Symptom Index and Beck Anxiety Scale (BAI). At the end of the study, the data will be evaluated in the SPSS program. The museum visit applied to the Intervention Group will also be applied to the control group after the study is completed, taking into account the ethical dimension.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Art Therapy Intervention Group | Experimental | Other: For the intervention group, a museum visit with virtual reality glasses will be applied.A total of five sessions of museum visits will applied to the patients in the intervention group, lasting 20-30 minutes during dialysis. The scales will administered to the individuals in the intervention groups three times in total. The intervention group is the group in which museum visit will applied. They receives 3 sessions of hemodialysis per week. |
| Control Group | No intervention | –No virtual museum visit was applied to the control group. Scales were applied to individuals. For the control group, evaluations were made with scales three times in total. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients who have been receiving hemodialysis treatment for at least one year, who are 18 years of age or older, who do not have difficulty in communicating, who are competent to answer all the questions, who do not have serious mental illness or mental problems, and who agree to participate in the research will be included in the study.
Key exclusion criteria (1 listed)
- Those who have just started hemodialysis treatment (< 1 year), those who have vision or hearing problems, those who have difficulty communicating, those under the age of 18, and those who do not want to participate in the study or want to leave will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| For the intervention group, a museum visit with virtual reality glasses will be applied.Patients will visit a museum while undergoing hemodialysis with virtual reality glasses for a total of five sessions for intervention group | Other | Art Therapy Intervention Group |
Primary outcome
Dialysis Symptom Index (DSI)
Time frame: It will take 5 weeks to collect data three times after randomization is done. The first measurement of dialyis symptom index will be done in the first week, the second measurement in the third week and the third measurement in the fifth week.
It was developed by HD patients in order to determine the symptoms experienced by HD patients and the level of impact on the patient. The scale, developed from the Memorial Symptom Diagnosis Scale Short Form, consists of 30 items. Responses are obtained on a 5-point Likert scale. The total scale score is obtained by adding up the scores obtained. This value varies between "0-15 0". The value "0" indicates that there is no symptom. The increase in the total points given to the answers towards 150 points shows that the effect of the mentioned symptom is increasing. The internal consistency coefficient of the scale was determined as 0.84.
Beck Anxiety Scale (BAI)
Time frame: It will take 5 weeks to collect data three times after randomization is done. The first measurement of Beck anxiety scale will be done in the first week, the second measurement in the third week and the third measurement in the fifth week.
It measures the frequency of anxiety symptoms experienced by the individual. It is a Likert-type self-evaluation scale consisting of twenty-one items and scored between 0-3. A high total score indicates the level of anxiety experienced by the person. The validity and reliability of the scale was determined in our country.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jan 2026.
- Background: PubMed 3204199Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
- BackgroundUlusoy M, Şahin N, Erkman H. Turkish Version of The Beck Anxiety Inventory: psychometric Properties. J Cognitive Psychotherapy: Int Quaterly. 1998; 12: 28-35.
- Results publication: PubMed 15010101Weisbord SD, Fried LF, Arnold RM, Rotondi AJ, Fine MJ, Levenson DJ, Switzer GE. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. J Pain Symptom Manage. 2004 Mar;27(3):226-40. doi: 10.1016/j.jpainsymman.2003.07.004.
- Individual participant dataSharing planned: Yes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing For the intervention group, a museum visit with virtual reality glasses will be applied. in people with DIALYSIS SYMPTOMS AND ANXIETY, run by Cumhuriyet University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dialysis Symptom Index (DSI) (time frame: It will take 5 weeks to collect data three times after randomization is done. The first measurement of dialyis symptom index will be done in the first week, the second measurement in the third week and the third measurement in the fifth week.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06382714, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2026; AzTrials last refreshed its copy on 8 Nov 2026.